NIT Rourkela Signs Technology Transfer Agreement with Miraqules Medsolutions for Anti-Bleeding Solution  

 

NIT Rourkela has been granted patents for two groundbreaking medical solutions developed by Prof. Devendra Verma and his research team from the Department of Biotechnology and Medical Engineering. These innovations are:

Nano-fibrous Polyelectrolyte Complex for Rapid Hemorrhage Control, Patent Number: 547492
Self-assembled Nano-fibers as Hemostatic Agent, Patent Number: 376918

To facilitate the commercialization of these patented technologies, the National Institute of Technology Rourkela (NITR) signed a technology transfer agreement with Miraqules Medsolutions Pvt. Ltd. on 25th September 2024 in the Board Room at NIT Rourkela. These patented medical solutions promise to transform emergency haemorrhage control.

The signing ceremony took place between Prof. K. Umamaheshwar Rao, Director of NIT Rourkela, and Mr. Sabir Hossain, CEO & Co-Founder of Miraqules Medsolutions, a biomedical startup specializing in anti-bleeding products. Miraqules’ flagship product, StopBleed, is capable of controlling bleeding faster than existing solutions, marking a significant advancement in emergency care.

This agreement represents the first technology transfer initiated by NIT Rourkela’s Intellectual Property Innovation Centre (IPIC), established in 2022. With around 50 granted patents in the last two years, IPIC fosters innovation and provides comprehensive support for the creation, protection, and management of intellectual property at the Institute. Prof. Saurav Chatterjee (Chairperson, IPIC) along with Prof. Rohan Dhiman, (Registrar), signed the agreement as witnesses from NITR. The event was attended by the Deans and IPIC members of NIT Rourkela as well as the members of the Miraqules team who joined virtually.

Prof. K. Umamaheshwar Rao commended both parties, emphasizing the significance of this startup-academia collaboration for societal benefit. In support of the initiative, Prof. H.B. Sahu, Dean of Alumni Industry and International Relations at NIT Rourkela proposed liaising with interested investors from the alumni network to help secure initial funding for the startup. Notably, Mr. Hossain is an alumnus of NIT Rourkela, having his M.Tech in 2018 from the Department of Biotechnology and Medical Engineering.

The ceremony also included remarks from Mr. Sabir Hossain, who expressed his gratitude to the NIT Rourkela team. He stated, “I am thankful to my alma mater for this support. This innovative product has the potential to save countless lives in both military and civilian medical emergency situations, especially in armed battles or road accidents. As a ‘Made in India’ product, it demonstrates strong export viability. We are already in discussions with the Indian Military and other organisations regarding its possible applications.”

Miraqules has received ISO 13485 certification, which is also known as a quality management system for medical devices.